AstraZeneca (AZN)

Share price graph

No market data available

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 6011.00p Today's change: +22.67%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 6011.00p 5 day change: N/A

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 6011.00p 6 month change: +18.37%

Contact details

Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com

Company information

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

The FTSE 100 lost ground today, down 5.31 points at 7,032.70 just before markets closed after a turbulent start [...]

16 November 2018

Shares in Astrazeneca dipped after the pharmaceutical giant revealed it had not reached the results it had hoped [...]

16 November 2018

Back in July 2016, Theresa May launched her campaign for leadership of the Conservative party by promising radical [...]

16 October 2018

The boards at several big-name companies will face a barrage of investor questions this week, as shareholders [...]

14 May 2018

British Gas owner Centrica said in a trading update today that its services division had been under pressure due [...]

14 May 2018

Major UK firms have told ministers of their fears that Brexit could leave them facing a shortfall of workers. [...]

1 April 2018

Those looking for an income from the stock market often turn to Equity Income funds. They provide a portfolio [...]

20 February 2018

Astrazeneca has hailed the success of its new Type 2 diabetes drugs, after a study of more than 300,000 people [...]

19 March 2017
Views
269

Shares in Neil Woodford-backed pharmaceuticals firm Circassia rocketed over 30 per cent this morning after [...]

17 March 2017
Views
205

Pharmaceuticals giant AstraZeneca has turned to an innovative startup helping patients, doctors and researchers [...]

15 March 2017
Shares
25
Views
381

AstraZeneca has struck a $320m (£256m) deal with TerSera Therapeutics to sell the commercial rights of its [...]

20 February 2017
Views
208

AstraZeneca shares slipped over one per cent after warning many of its patents will run out during 2017. [...]

2 February 2017
Views
497

AstraZeneca is forecast to report disappointing results this week as competition continues to drag on sales. [...]

29 January 2017
Views
563

London's top share index hit a fresh all-time high yesterday, setting a record for the longest winning streak [...]

11 January 2017
Shares
15
Views
310

2016's events made fools of most pundits, and looking back at my column exactly a year ago, I fared little better. [...]

6 January 2017
Shares
9
Views
1,250

Content tagged with "AstraZeneca"